[go: up one dir, main page]

ATE161178T1 - Pyrazolpyridine für die behandlung der anämie - Google Patents

Pyrazolpyridine für die behandlung der anämie

Info

Publication number
ATE161178T1
ATE161178T1 AT93913487T AT93913487T ATE161178T1 AT E161178 T1 ATE161178 T1 AT E161178T1 AT 93913487 T AT93913487 T AT 93913487T AT 93913487 T AT93913487 T AT 93913487T AT E161178 T1 ATE161178 T1 AT E161178T1
Authority
AT
Austria
Prior art keywords
pct
anemia
date dec
treatment
sec
Prior art date
Application number
AT93913487T
Other languages
English (en)
Inventor
Yutaka Kohno
Itsuo Nagatomi
Kaori Hanaoka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212264A external-priority patent/GB9212264D0/en
Priority claimed from GB929215794A external-priority patent/GB9215794D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE161178T1 publication Critical patent/ATE161178T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT93913487T 1992-06-10 1993-06-07 Pyrazolpyridine für die behandlung der anämie ATE161178T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212264A GB9212264D0 (en) 1992-06-10 1992-06-10 New use of the pyrazolopyridine compound
GB929215794A GB9215794D0 (en) 1992-07-24 1992-07-24 New use of the pyrazolopyridine compound

Publications (1)

Publication Number Publication Date
ATE161178T1 true ATE161178T1 (de) 1998-01-15

Family

ID=26301043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93913487T ATE161178T1 (de) 1992-06-10 1993-06-07 Pyrazolpyridine für die behandlung der anämie

Country Status (6)

Country Link
US (1) US5643938A (de)
EP (1) EP0644762B1 (de)
JP (1) JP3269084B2 (de)
AT (1) ATE161178T1 (de)
DE (1) DE69315836T2 (de)
WO (1) WO1993025205A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996035502A1 (en) * 1995-05-10 1996-11-14 Bord Na Mona An effluent treatment system
WO1997040047A1 (fr) * 1996-04-25 1997-10-30 Fujisawa Pharmaceutical Co., Ltd. Medicaments pour la prevention et le traitement des lesions et de l'ileus par ischemie intestinale
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0972525A4 (de) 1997-03-18 2000-11-29 Fujisawa Pharmaceutical Co Vorbeugende und heilende mittel gegen hyperphosphatämie
DE19904396A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolbenzylamin-Derivate
DE19904406A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Substituierte Pyrazolcarbonsäuren
DE19929785A1 (de) * 1999-06-29 2001-01-04 Bayer Ag Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung
US20050282751A1 (en) * 2004-03-19 2005-12-22 Ajinomoto Co., Inc. Therapeutic agent for renal anemia
WO2009016812A1 (ja) * 2007-07-27 2009-02-05 Kowa Company, Ltd. ２－フェニルキノリン－４－カルボン酸誘導体を有効成分とする貧血の予防及び／又は治療剤
CA2739422C (en) * 2008-10-02 2013-03-12 Eli Lilly And Company Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes
EP2655362A1 (de) 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis-c-inhibitoren und ihre verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
US5338743A (en) * 1988-06-06 1994-08-16 Fujisawa Pharmaceutical Co., Ltd. New use of the adenosine antagonist
GB8901423D0 (en) * 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5459031A (en) * 1993-11-05 1995-10-17 Amgen Inc. Methods for controlling sialic acid derivatives in recombinant glycoproteins

Also Published As

Publication number Publication date
JP3269084B2 (ja) 2002-03-25
DE69315836D1 (de) 1998-01-29
DE69315836T2 (de) 1998-04-09
EP0644762B1 (de) 1997-12-17
EP0644762A1 (de) 1995-03-29
US5643938A (en) 1997-07-01
JPH08500338A (ja) 1996-01-16
WO1993025205A1 (en) 1993-12-23

Similar Documents

Publication Publication Date Title
ATE202076T1 (de) Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
HUT65351A (en) Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent
ATE161178T1 (de) Pyrazolpyridine für die behandlung der anämie
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ES2141827T3 (es) Peptidos que tienen actividad antagonista de endotelina, su preparacion y composiciones farmaceuticas de los mismos.
ES2104938T3 (es) Metodo de inhibir la fibrosis.
ATE169635T1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
IL105122A0 (en) Benzimidazole derivative for use as an anti-irritant
PL313037A1 (en) Phenoxphenylocyclopententenylohydroxyureas
MX9201055A (es) N-[[4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracen-il] carbonil] aminoacidos utiles en la terapia de afecciones osteoarticulares.
KR950032194A (ko) 신규푸린유도체 및 그 약학적으로 허용되는 염
DE69414396D1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
KR950703341A (ko) 항부정맥제
DE59406568D1 (de) Cephalostatin-analoga und ihre verwendung als antitumormittel
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.
EP0823254A4 (de) Neue verwendung von pyrazolopyridinverbindungen
ES2107799T3 (es) Compuestos de cefema de actividad antimicrobiana.